Ansell Crescita futura

Future criteri di controllo 4/6

Ansell prevede che gli utili e i ricavi cresceranno rispettivamente di 22.8% e 6.7% all'anno. Si prevede che l'EPS crescerà di 21% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 9.9% in 3 anni.

Informazioni chiave

22.8%

Tasso di crescita degli utili

21.0%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	16.2%
Tasso di crescita dei ricavi	6.7%
Rendimento futuro del capitale proprio	9.9%
Copertura analitica	Good
Ultimo aggiornamento	01 Nov 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Previsioni di crescita degli utili e dei ricavi

CHIA:ANN - Stime future degli analisti e dati finanziari passati (USD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2027	2,080	212	236	287	11
6/30/2026	2,007	189	235	285	11
6/30/2025	1,928	134	146	213	11
6/30/2024	1,619	77	210	272	N/A
3/31/2024	1,612	90	188	256	N/A
12/31/2023	1,605	104	167	239	N/A
9/30/2023	1,630	126	140	210	N/A
6/30/2023	1,655	148	113	181	N/A
3/31/2023	1,717	147	145	213	N/A
12/31/2022	1,778	145	178	245	N/A
9/30/2022	1,865	152	166	234	N/A
6/30/2022	1,952	159	155	222	N/A
3/31/2022	2,025	188	106	176	N/A
12/31/2021	2,098	218	58	130	N/A
9/30/2021	2,063	232	74	152	N/A
6/30/2021	2,027	247	90	173	N/A
3/31/2021	1,913	222	142	222	N/A
12/31/2020	1,798	197	194	270	N/A
9/30/2020	1,706	177	210	279	N/A
6/30/2020	1,614	157	226	287	N/A
3/31/2020	1,570	147	190	246	N/A
12/31/2019	1,527	138	154	204	N/A
9/30/2019	1,513	125	149	197	N/A
6/30/2019	1,499	112	145	189	N/A
3/31/2019	1,496	112	136	181	N/A
12/31/2018	1,493	112	127	172	N/A
9/30/2018	1,491	125	118	163	N/A
6/30/2018	1,490	139	108	154	N/A
3/31/2018	1,461	135	N/A	172	N/A
12/31/2017	1,433	132	N/A	190	N/A
9/30/2017	1,404	125	N/A	203	N/A
6/30/2017	1,375	119	N/A	216	N/A
12/31/2016	1,232	121	N/A	231	N/A
9/30/2016	1,292	129	N/A	232	N/A
6/30/2016	1,353	137	N/A	232	N/A
3/31/2016	1,578	164	N/A	212	N/A
12/31/2015	1,583	169	N/A	191	N/A
9/30/2015	1,614	178	N/A	195	N/A
6/30/2015	1,645	188	N/A	200	N/A
3/31/2015	1,690	126	N/A	231	N/A
12/31/2014	1,734	64	N/A	262	N/A
9/30/2014	1,662	53	N/A	242	N/A
6/30/2014	1,590	42	N/A	221	N/A
3/31/2014	1,507	95	N/A	179	N/A
12/31/2013	1,425	148	N/A	137	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di ANN ( 22.8% all'anno) è superiore al tasso di risparmio ( 2.6% ).

Guadagni vs Mercato: Si prevede che gli utili di ANN ( 22.8% all'anno) cresceranno più rapidamente del mercato Australian ( 12.4% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di ANN cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di ANN ( 6.7% all'anno) crescerà più rapidamente del mercato Australian ( 5.7% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di ANN ( 6.7% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di ANN sarà basso tra 3 anni ( 9.9 %).

Ansell Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Ansell Limited Provides Earnings Guidance for the Year 2024

Ansell Limited Provides Earnings Guidance for the Full Year Ended 30 June 2023 and Fiscal Year 2024

Ansell Limited Revises Earnings Guidance for the Fiscal Year 2022

Ansell Limited Provides Earnings Guidance for the Fiscal Year 2022

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

Recent updates

Ansell Limited Announces Zubair Javeed Intention to Resign as Chief Financial Officer

Final dividend of US$0.22 announced

Ansell Limited Announces Final Dividend for the Year Ended June 30, 2024 , Payable on September 12, 2024

New minor risk - Profit margin trend

Full year 2024 earnings released: EPS: US$0.59 (vs US$1.17 in FY 2023)

Ansell Limited (ASX:ANN) completed the acquisition of Personal Protective Equipment business of Kimberly-Clark Corporation (NYSE:KMB).

Ansell Limited to Report Fiscal Year 2025 Results on Aug 26, 2025

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

First half dividend of US$0.17 announced

First half 2024 earnings released: EPS: US$0.15 (vs US$0.51 in 1H 2023)

Ansell Limited Declares Dividend for the Six Months Ended December 31, 2023, Payable on March 14, 2024

Ansell Limited Provides Earnings Guidance for the Year 2024

Ansell Limited Declares Final Dividend for Year Ended 30 June 2023, Payable on 7 September 2023

Full year 2023 earnings released: EPS: US$1.18 (vs US$1.25 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Ansell Limited Provides Earnings Guidance for the Full Year Ended 30 June 2023 and Fiscal Year 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Now 21% undervalued after recent price drop

Ansell Limited Announces Board Changes, Effective on 24 October 2023

First half 2023 earnings released: EPS: US$0.51 (vs US$0.61 in 1H 2022)

Now 24% undervalued after recent price drop

Ansell Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 9, 2023

Ansell Limited Announces Appointment of Debra Goodin as an Independent Nonexecutive Director

Non-Executive Director recently bought AU$130k worth of stock

Ansell Limited to Report First Half, 2023 Results on Feb 14, 2023

Full year 2022 earnings released: EPS: US$1.25 (vs US$1.92 in FY 2021)

Ansell Limited, Annual General Meeting, Oct 26, 2023

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Ansell Limited Announces Dividend for the Period of Six Months Ended December 31, 2021, Payable on March 09, 2022

Investor sentiment deteriorated over the past week

Ansell Limited Revises Earnings Guidance for the Fiscal Year 2022

High number of new directors

Ansell Limited Provides Earnings Guidance for the Fiscal Year 2022

Full year 2021 earnings released: EPS US$1.92 (vs US$1.22 in FY 2020)

New 90-day high: AU$39.25

First half 2021 earnings released: EPS US$0.83 (vs US$0.50 in 1H 2020)

Revenue misses expectations

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

Ansell Limited (ASX:ANN) acquired life science business from Primus Gloves Private Limited and SANREA Healthcare Products Pvt Limited.

Independent Non-Executive Director recently sold AU$260k worth of stock

New 90-day low: AU$35.58

MD, CEO & Executive Director recently sold AU$3.2m worth of stock

New 90-day high: AU$42.03

New 90-day high: AU$41.05

Independent Non-Executive Director recently bought AU$55k worth of stock

Independent Non-Executive Director recently bought AU$55k worth of stock

Full year earnings released - EPS AU$1.22

Ansell Limited to Report Fiscal Year 2021 Results on Aug 24, 2021

New 90-day high - AU$40.57

New 90-day high - AU$39.20

Ansell Limited (ASX:ANN) completed the acquisition 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS).

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita